drug

goserelin

1 story · latest Aug 7, 2026

Status: FDA approved Dec 1989 · NDA019726, NDA020515, NDA020578
Brand: Zoladex
Trials: 5 registered trials in coverage

Timeline

Atossa reports Q2 2026 results, completes enrollment in EVANGELINE trial

Aug 7Quarterly updateAtossa Therapeutics, Inc.endoxifen

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.